Showing results (1101-1110 of 1,984) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|November 23, 2019
The gut microbiome in neurological disordersJohn F Cryan, Kenneth J O'Riordan, Kiran Sandhu, et al.
The Lancet. Neurology|December 24, 2013
Secondary stroke preventionGraeme J Hankey
The Lancet. Neurology|December 17, 2013
Body fluid biomarkers in multiple sclerosisManuel Comabella, Xavier Montalban
The Lancet. Neurology|March 20, 2021
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trialChrista Walgaard, Bart C Jacobs, Hester F Lingsma, et al.
The Lancet. Neurology|March 20, 2021
Epilepsy in China: major progress in the past two decadesDing Ding, Dong Zhou, Josemir W Sander, et al.
The Lancet. Neurology|November 28, 2021
Blood-based biomarkers for Alzheimer's disease: towards clinical implementationCharlotte E Teunissen, Inge M W Verberk, Elisabeth H Thijssen, et al.
The Lancet. Neurology|March 25, 2021
Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trialStefan T Engelter, Christopher Traenka, Henrik Gensicke, et al.
The Lancet. Neurology|February 20, 2021
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trialGünter U Höglinger, Irene Litvan, Nuno Mendonca, et al.
The Lancet. Neurology|February 20, 2021
New insights into atypical Alzheimer's disease in the era of biomarkersJonathan Graff-Radford, Keir X X Yong, Liana G Apostolova, et al.
The Lancet. Neurology|March 1, 2021
Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trialMikael Mazighi, Sebastien Richard, Bertrand Lapergue, et al.
Pageof 199